Breakthrough Review from Australian Universities Links Vaping to Serious Cancer Risks

A landmark scientific review conducted by researchers from leading Australian institutions, including the University of New South Wales (UNSW Sydney), has concluded that nicotine-based vaping products are likely to cause lung and oral cancers. This qualitative risk assessment, published in the journal Carcinogenesis, synthesizes evidence from over 100 studies spanning 2017 to 2025, marking the strongest determination to date that vaping poses a direct carcinogenic threat independent of traditional tobacco smoking.

The multidisciplinary team, comprising epidemiologists, thoracic surgeons, pharmacists, and public health experts, analyzed clinical data, animal experiments, and laboratory analyses. Their findings underscore the urgency for public health interventions, particularly as vaping gains traction among young Australians, including university students navigating high-pressure academic environments.

Led by Adjunct Professor Bernard Stewart from UNSW Sydney, the study highlights biological changes in lung and oral tissues—such as DNA damage, oxidative stress, and chronic inflammation—that are hallmarks of cancer development. Professor Stewart emphasized, "There is no doubt that the cells and tissues of the oral cavity, the mouth, and the lungs are altered by inhalation from e-cigarettes."

Understanding the Evidence: A Multi-Faceted Approach to Assessing Vaping Dangers

The review employed a rigorous qualitative framework, drawing parallels to historical assessments of tobacco's carcinogenicity by the International Agency for Research on Cancer (IARC). Evidence was categorized into three pillars: human biomarkers indicating pre-cancerous changes, animal models demonstrating tumor formation, and mechanistic studies revealing toxicological pathways.

Human studies revealed elevated levels of DNA adducts—molecular scars from chemical exposure—in vapers' oral and lung cells, alongside markers of inflammation and oxidative stress. These changes mirror early stages observed in smokers before cancer manifests. Case reports from dentists documented oral cancers in never-smokers who exclusively vaped, providing rare but compelling clinical anecdotes.

Animal experiments were particularly damning: mice exposed to e-cigarette aerosols developed lung tumors at significantly higher rates than controls. Laboratory analyses identified over 2,000 chemicals in vape aerosols, including known carcinogens like formaldehyde, acrolein, and heavy metals (nickel, chromium) leached from heating coils. Flavorings such as cinnamaldehyde further exacerbated cytotoxicity and immune disruption.

Co-author Associate Professor Freddy Sitas from UNSW noted the consistency across disciplines: "The evidence was remarkably consistent across fields. It dictated an unequivocal finding now, though human studies that estimate the risk will take decades."

Australian Universities at the Forefront: Collaborations Driving Cancer Research

This pivotal work exemplifies collaborative higher education efforts in Australia. UNSW Sydney spearheaded the review, with contributions from the University of Sydney's School of Public Health, the University of Queensland, and Flinders University. Clinical insights came from specialists at Royal North Shore Hospital, The Prince Charles Hospital, and Sunshine Coast University Hospital.

Such interdisciplinary partnerships highlight Australia's strength in public health research. Professor Becky Freeman from the University of Sydney reinforced the findings: "This study is the first to assert that there is likely an increased cancer risk for people who vape, compared to people who do not vape." These institutions continue to lead in tobacco control, with ongoing projects exploring vaping's gateway effects to nicotine dependence among students.

University campuses have become hotspots for vaping, prompting initiatives like UNSW's health education campaigns and Sydney's peer-led quit programs. For aspiring researchers, opportunities abound in these labs, where studies blend epidemiology, toxicology, and policy analysis to combat emerging threats like vaping.

Rising Vaping Prevalence Among Australian Youth and University Students

Vaping has surged in Australia since e-cigarettes emerged around 2008, particularly among adolescents and young adults. By 2023, nearly 30% of secondary students aged 14-17 had tried vaping, with 12.9% of 12-15-year-olds vaping monthly. Recent 2026 data shows some decline—NSW teens vaping 100+ times dropped from 6.4% to 2.6%—yet 18-24-year-olds remain at highest risk, with 28% ever vaping and half of current users never having smoked.

On campuses, vaping is ubiquitous outside lecture halls and libraries, driven by flavors mimicking candy and fruit. University students, facing exam stress, often turn to vapes for perceived relaxation, unaware of long-term perils. A 2025 survey indicated 21% of 18-24-year-olds currently vape, equating to over 225,000 young never-smokers at potential risk.

This trend alarms educators, as nicotine addiction impairs cognitive function and academic performance. Australian universities are responding with targeted interventions, integrating anti-vaping modules into health curricula.

Photo by Eriksson Luo on Unsplash

Beyond Cancer: Other Health Impacts of Vaping Highlighted in the Review

While lung and oral cancers dominate concerns, the UNSW-led review flags additional risks: cardiovascular disease from vascular inflammation, respiratory issues like popcorn lung (bronchiolitis obliterans) from diacetyl in flavors, and nicotine's role in fetal brain development if used during pregnancy. Dual users—common among quit-attempting smokers—face quadrupled lung cancer odds.

Emerging data links vaping to EVALI (e-cigarette or vaping product use-associated lung injury), with metals and vitamin E acetate implicated in severe cases. For oral health, leukoplakia—white patches precursor to cancer—appears in vapers' mouths. These multifaceted harms necessitate holistic prevention strategies in academic settings.

Policy Responses: Australia's Regulatory Framework and Calls for Stronger Enforcement

Australia pioneered strict vaping laws in 2021, confining nicotine vapes to prescription-only pharmacy sales for quitting smokers. 2023 reforms banned imports of non-therapeutic vapes, yet black-market proliferation—fueled by cheap, flavored disposables—undermines efforts. The study urges full enforcement, likening delays to 20th-century tobacco inaction.

Experts advocate pharmacy-only models, public awareness campaigns, and campus bans. Universities like Flinders and UQ support these via research-backed advocacy. The Department of Home Affairs reports record seizures, but critics note illicit vapes often contain undeclared nicotine, deceiving users.

Internationally, Australia's approach influences policy, positioning its universities as global leaders in evidence-based tobacco control.

Quitting Vaping: University-Led Support and Effective Strategies

Universities play a crucial role in cessation. UNSW's Thrive program offers free counseling, nicotine replacement therapy (NRT), and apps like QuitNow. Evidence supports behavioral therapy combined with NRT—patches, gums—over cold turkey, with success rates doubling.

• Step 1: Assess dependence via Fagerström Test (quick 6-question tool).
• Step 2: Consult campus health services for personalized NRT plans.
• Step 3: Join peer support groups; mindfulness apps reduce cravings by 40%.
• Step 4: Track progress with journals; avoid triggers like social vaping.
• Step 5: Celebrate milestones—research shows rewards boost adherence.

Pharmacotherapies like varenicline show promise for vapers, per Sydney University trials. For students, integrating quit support into wellness centers ensures accessibility amid academic demands.

Future Outlook: Ongoing Research at Australian Higher Education Institutions

Australian universities are gearing up for longitudinal studies tracking vapers' cancer incidence. UNSW plans a 10-year cohort of young adults, while UQ explores genetic susceptibilities. Funding from NHMRC prioritizes vaping's youth impact, fostering PhD opportunities in oncology and epidemiology.

Collaborations with international bodies like WHO aim to standardize testing for vape carcinogens. Innovations include AI-driven risk modeling at Flinders, predicting individual vulnerabilities. These efforts position Australia—and its universities—as pioneers in mitigating vaping's public health crisis.

Photo by Gilberto Olimpio on Unsplash

Stakeholder Perspectives: Balancing Harm Reduction and Prevention

While the review quells debates on vaping's relative safety, stakeholders diverge. Tobacco control advocates like Cancer Council Australia hail it as a wake-up call; harm reduction proponents caution against overstatement absent epi data. Professor Richard Edwards (Flinders) notes vaping may aid some smokers quitting, but not non-smokers.

University ethicists emphasize precautionary principles, prioritizing youth protection. Patient stories—young vapers facing oral lesions—humanize risks, spurring campus dialogues.